IM Cannabis' Q3 Earnings: Unpacking Revenue And Profit Shifts
Portfolio Pulse from Patricio Liddle
IM Cannabis Corp (NASDAQ:IMCC) reported a 13% decrease in Q3 2023 revenue compared to the same period last year, with figures at CA$12.4 million. The company saw a net loss from continuing operations of CA$2.1 million, which is an improvement from CA$4.5 million in Q3 2022. Adjusted EBITDA loss decreased by 65% to CA$1.3 million, and gross profit increased by 30% to CA$2.6 million. Operating loss also decreased by 58% to CA$2.3 million. CEO Oren Shuster emphasized the company's move towards sustainable profitability and focus on high-end products in the Israeli market. CFO Itay Vago highlighted the impact of currency volatility but noted operational cost reductions. The company launched high THC strains and outsourced delivery services to save costs, amidst geopolitical tensions in Israel. IMCC's stock was up 1.03% at $0.44 per share.
November 14, 2023 | 7:26 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
IM Cannabis Corp reported a decrease in Q3 revenue but showed improvements in net loss, gross profit, and operating loss. The company is focusing on high-end products and cost-saving measures, despite market uncertainties.
While IMCC's revenue has decreased, the improvement in net loss, gross profit, and operating loss, along with the company's strategic focus on high-end products and cost-saving measures, may provide a neutral to slightly positive outlook for investors. The stock's slight increase post-earnings release indicates a cautiously optimistic market response. However, geopolitical tensions could introduce volatility and uncertainty, tempering the potential positive impact.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100